We would like to bring to your attention several articles which we recently published on LinkedIn and which highlight the benefits of conducting clinical trials in the UK.
Why the UK is the best country for your European clinical trials?
This first article discusses the benefits of conducting clinical trials in the UK. It mentions the streamlined study set up process, the experienced staff, the influential UK regulators together with the ability to have regulations independent of the European Union which provides more flexibility and reduces the regulatory burden.
You can also watch our video overview.
The UK is the best country for your phase 1 clinical trial
Our second article discusses the great advantages of setting up phase 1 clinical trials in the UK. It mentions the advantages over Australia which is a gold standard for phase 1 clinical trials for many USA companies. You can also learn about the current timelines to obtain approval for phase 1 clinical trials and also learn about the phase 1 clinical sites.
Our video overview is available here.
Why should UK be your top priority for obtaining marketing authorisation?
The third article provides insights on obtaining marketing authorisation in the UK. It mentions the benefits of obtaining marketing authorisation in the UK and also discusses the marketing authorisation process in the European Union (EU). If you think that marketing authorisation in the EU gives you automatic rights to sell in all countries then you need to read this article.
You can also watch out short video on the topic.
Why UK is the best European country for your biotech startup?
If you are working in a pharma or biotech startup we strongly recommend you our forth article which explains why UK is the best country for startups and not surprisingly the UK was the third country to achieve $1 trillion value after the USA and China. You can also learn about a lot of initiative designed to help startups trying to reach the UK market.
You can also watch our short video.
Those of you interested in regulatory updates can follow our monthly newsletter on LinkedIn which covers the latest updates from around the world.
